Human Tacheng Tick Virus 2 Infection, China, 2019
Zhihui Dong
1, Meihua Yang
1, Zedong Wang
1, Shuo Zhao, Songsong Xie, Yicheng Yang, Gang Liu, Shanshan Zhao, Jing Xie, Quan Liu

, and Yuanzhi Wang
Author affiliations: Shihezi University, Shihezi, China (Z. Dong, M. Yang, Shuo Zhao, Y. Yang, G. Liu, Shanshan Zhao, Y. Wang); Foshan University, Foshan, China (Z. Wang, Q. Liu); First Affiliated Hospital of Shihezi University, Shihezi (S. Xie, J. Xie); Shihezi People’s Hospital, Shihezi (Y. Yang)
Main Article
Table
Results of immunofluorescence assay in detection of Tacheng tick virus 2 infection in a human, China*
Days after illness onset |
Sample type |
IFA titer
|
IgM |
IgG |
Day 9
|
Serum |
1:40 |
<1:10 |
Urine |
<1:10 |
<1:10 |
CSF
|
<1:10
|
<1:10
|
Day 16
|
Serum |
1:20 |
1:10 |
Urine |
<1:10 |
<1:10 |
CSF
|
<1:10
|
<1:10
|
Day 40 |
Serum |
<1:10 |
1:80 |
Urine |
<1:10 |
<1:10 |
CSF |
<1:10 |
<1:10 |
Main Article
Page created: December 23, 2020
Page updated: February 02, 2021
Page reviewed: February 02, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.